Method and apparatus for treating fluid build-up in a body cavity, including method and apparatus for treating ascites and pleural effusions

ABSTRACT

A method for treating pleural effusion in a patient, the method comprising: providing a valve comprising: a body having a distal end, a proximal end and a lumen extending therebetween; an inlet disposed at the proximal end of the body, the inlet being fluidically connected to the lumen; an outlet disposed at the distal end of the body, the outlet being fluidically connected to the lumen; and at least one valve element disposed in the lumen of the body, the at least one valve element being a one-way valve element configured to permit the passage of fluid in a single direction through the lumen of the body; and implanting the valve in the body of the patient such that the inlet of the valve is fluidically connected to the pleural cavity of the patient, and such that the outlet of the valve is fluidically connected to a second body cavity.

REFERENCE TO PENDING PRIOR PATENT APPLICATION

This patent application is a continuation-in-part of pending prior U.S.patent application Ser. No. 15/426,184, filed Feb. 7, 2017 by ewimed andAlbertus Scheule et al. for METHOD AND APPARATUS FOR TREATING ASCITES,which patent application is hereby incorporated herein by reference.

FIELD OF THE INVENTION

The present invention relates to methods and apparatus for treatingmedical conditions in general, and more particularly to a novel methodand apparatus for treating fluid build-up in a body cavity, including anovel method and apparatus for treating ascites, pleural effusions, etc.

BACKGROUND OF THE INVENTION

Ascites is the condition of pathologic fluid collection within theabdominal cavity, in particular within the peritoneal cavity. Ascitescan be caused by different diseases, e.g., cirrhosis, cancer and heartfailure, among other diseases.

One way of treating ascites is by the direct removal of the excess fluidfrom the abdominal cavity. Such direct removal is typically effected bypuncturing the abdominal wall (e.g., with a needle) and using a pump(e.g., a syringe) to generate suction to remove the fluid from the body.See, for example, FIG. 1 , which shows direct removal of excess fluidfrom the abdominal cavity via drainage to a collection bag 5; and FIG. 2, which shows direct removal of excess fluid from the abdominal cavityusing a syringe 10. Inasmuch as the excess fluid removed from the bodytypically contains important biological components which should not bediscarded, the fluid that is removed from the body may thereafter bere-introduced into the body at a different location, e.g., the jugularvein. Since excess fluid may build up again in the abdominal cavity evenafter removal of fluid, repetition of the removal and re-introductionprocedure may be necessary.

In order to decrease the burden on the patient (i.e., the burdenresulting from continued invasive procedures which are needed in orderto access the abdominal cavity to remove fluid and to re-introduce thefluid into the body at a different location), shunts may be implantedinto the body of the patient to connect the peritoneal cavity with themajor thoracic vein via flexible tubing. See, for example, FIGS. 3 and 4, which show an exemplary catheter 15 which may be used as a shunt. Aone-way valve 20 is typically provided in catheter 15 in order tocontrol the direction of fluid flow (i.e., to allow the fluid to flow inonly one direction, from the abdominal cavity to the thoracic vein).Such shunts are commonly referred to as peritoneovenous (or “P-V”)shunts. The one-way fluid flow through a P-V shunt is typically causedby pressure which is generated during respiration (i.e., when mechanicalimpingement of the diaphragm on the ascetic fluid pressurizes the fluid,causing the fluid to flow into the P-V shunt). Most of the ascetic fluidwhich is introduced into the major thoracic vein is ultimately excretedfrom the body as urine, while plasma proteins which are present in theascetic fluid are retained in the blood.

By way of example but not limitation, EP 0 806 970 A1 shows an improvedvalve which may be used in a typical P-V shunt. However, the valve of EP0 806 970 A1 is positioned between the peritoneal tubing of the P-Vshunt and the venous tubing of the P-V shunt. As a result, with such avalve, there is a significant risk of the failure of the P-V shunt dueto blocking of the peritoneal tubing (and possibly also the venoustubing) by the pressure created against the tubing in the abdominalcavity. In addition, the long distance traversed by the P-V shunt (i.e.,the distance from the patient's abdominal cavity to the patient's majorthoracic vein) requires a long shunt and an invasive procedure toimplant the shunt in the patient's body.

Thus there is a need for a new and improved method and apparatus for thetreatment of ascites which eliminates the problems encountered whenusing long shunts, which allows for the recirculation of ascetic fluidwithout removing it from the patient's body, and which places as littleburden on the patient as possible.

Other pathologic conditions may also result in fluid build-up within abody cavity and require treatment through removal of the fluid from thebody cavity. By way of example but not limitation, one such pathologiccondition is pleural effusion, the build-up of fluid within the pleuralcavity, and particularly fluid build-up in the space between thevisceral pleural layer and the parietal pleural layer. Pleural effusionis typically treated by draining excess fluid from the pleural cavityusing a catheter connected to an external suction source (e.g., a pump),however, such an approach is disadvantageous in that fluid often buildsup again in the plural cavity (requiring another catheter-basedintervention to drain), the fluid may not be transfused back into thepatient and excessive loss may cause hypoproteinemia, and/or the use ofa drainage catheter may cause infections (e.g., empyema).

Thus there is also a need for a new and improved method and apparatusfor the treatment of fluid build-up in a body cavity, particularly fluidbuild-up in the pleural cavity, which eliminates the problemsencountered when using drainage catheters, which allows for therecirculation of fluid removed from the body cavity without removing itfrom the patient's body, and which places as little burden on thepatient as possible.

SUMMARY OF THE INVENTION

The present invention eliminates the need for long shunts, and theburden imposed on the patient by implanting long shunts within thepatient's body, while avoiding the need to remove fluid from, andre-introduce fluid into, the patient's body. As a result, the presentinvention is able to significantly reduce the burden on the patientwhich is typically encountered when using traditional P-V shunts (e.g.,resistance to fluid flow and higher occlusion rates).

More particularly, the present invention comprises the provision and useof a novel implantable one-way valve, and a method for treating apatient using the novel implantable one-way valve, so as to provide adirect connection between the abdominal cavity and the venous system ofthe patient.

In addition, the present invention also comprises the provision and useof a novel implantable one-way valve, and a method for treating apatient using the novel implantable one-way valve, so as to treat fluidbuild-up in a body cavity, particularly fluid build-up in the pleuralcavity, which eliminates the problems encountered when using drainagecatheters, which allows for the recirculation of fluid removed from thebody cavity without removing it from the patient's body, and whichplaces as little burden on the patient as possible.

In one preferred form of the present invention, there is provided avalve for treating ascites, the valve comprising:

-   -   a body having a distal end, a proximal end and a lumen extending        therebetween;    -   at least one valve element disposed in the lumen of the body,        the at least one valve element being a one-way valve element        configured to permit the passage of fluid in a single direction        through the lumen of the body; and    -   at least one connection element provided on at least one of the        distal end and the proximal end of the body, wherein the at        least one connection element is configured to connect the body        of the valve to the side wall of a blood vessel.

In another preferred form of the present invention, there is provided amethod of treating ascites, the method comprising:

-   -   implanting a one-way valve into the side wall of a blood vessel        located adjacent the abdominal cavity, so that one side of the        valve lies within, and is fluidically connected to, the        abdominal cavity and the other side of the valve lies within,        and is fluidically connected to, the interior of the blood        vessel.

In another preferred form of the present invention, there is provided avalve for treating ascites, the valve comprising:

-   -   a body having a distal end, a proximal end and a lumen extending        therebetween;    -   at least one valve element mounted to the distal end of the body        and extending distally therefrom, the at least one valve element        being a one-way valve element configured to permit the passage        of fluid in a single direction through the lumen of the body;        and    -   at least one connection element provided on at least one of the        distal end and the proximal end of the body, wherein the at        least one connection element is configured to connect the body        of the valve to the side wall of a blood vessel.

In another preferred form of the present invention, there is provided amethod for treating pleural effusion in a patient, the methodcomprising:

-   -   providing a valve comprising:        -   a body having a distal end, a proximal end and a lumen            extending therebetween;        -   an inlet disposed at the proximal end of the body, the inlet            being fluidically connected to the lumen;        -   an outlet disposed at the distal end of the body, the outlet            being fluidically connected to the lumen; and        -   at least one valve element disposed in the lumen of the            body, the at least one valve element being a one-way valve            element configured to permit the passage of fluid in a            single direction through the lumen of the body; and    -   implanting the valve in the body of the patient such that the        inlet of the valve is fluidically connected to the pleural        cavity of the patient, and such that the outlet of the valve is        fluidically connected to a second body cavity.

In another preferred form of the present invention, there is provided avalve for draining fluid from a pleural cavity of a patient into asecond body cavity of a patient, the valve comprising:

-   -   a body having a distal end, a proximal end and a lumen extending        therebetween, wherein the distance between the distal end of the        body and the proximal end of the body is at least as great as        the distance between the pleural cavity of a patient and the        abdominal cavity of a patient;    -   an inlet disposed at the proximal end of the body, the inlet        being fluidically connected to the lumen;    -   an outlet disposed at the distal end of the body, the outlet        being fluidically connected to the lumen; and    -   at least one valve element disposed in the lumen of the body,        the at least one valve element being a one-way valve element        configured to permit the passage of fluid in a single direction        through the lumen of the body.

In another preferred form of the present invention, there is provided amethod for draining fluid from a first body cavity of a patient into asecond body cavity of a patient, the method comprising:

-   -   providing a valve comprising:        -   a body having a distal end, a proximal end and a lumen            extending therebetween;        -   an inlet disposed at the proximal end of the body, the inlet            being fluidically connected to the lumen;        -   an outlet disposed at the distal end of the body, the outlet            being fluidically connected to the lumen; and        -   at least one valve element disposed in the lumen of the            body, the at least one valve element being a one-way valve            element configured to permit the passage of fluid in a            single direction through the lumen of the body; and    -   implanting the valve in the body of the patient such that the        inlet of the valve is fluidically connected to the first body        cavity, and such that the outlet of the valve is fluidically        connected to the second body cavity.

BRIEF DESCRIPTION OF THE DRAWINGS

These and other objects and features of the present invention will bemore fully disclosed or rendered obvious by the following detaileddescription of the preferred embodiments of the invention, which is tobe considered together with the accompanying drawings wherein likenumbers refer to like parts, and further wherein:

FIG. 1 is a schematic view showing how ascetic fluid may be removed fromthe abdomen of a patient using a drainage bag;

FIG. 2 is a schematic view showing how ascetic fluid may be removed fromthe abdomen of a patient using a syringe;

FIGS. 3 and 4 are schematic views of a prior art P-V shunt which may beused to remove fluid from the abdomen of a patient and re-introduce thefluid into the patient at a remote location;

FIGS. 5-8 are schematic views showing a novel one-way valve formed inaccordance with the present invention;

FIG. 9 is a schematic view showing the one-way valve of FIGS. 5-8implanted in the side wall of a blood vessel;

FIG. 10 is a schematic view showing a novel delivery system which may beused to deliver a novel one-way valve to an internal anatomical site;

FIGS. 11-13 are schematic views showing how a novel one-way valve formedin accordance with the present invention may be implanted into the sidewall of a blood vessel using an “abdominal approach”;

FIGS. 14, 15, 15A and 15B are schematic views showing how a novelone-way valve formed in accordance with the present invention may beimplanted into the side wall of a blood vessel using an “endoluminalapproach”;

FIGS. 16-18 are schematic views showing another novel one-way valveformed in accordance with the present invention;

FIG. 19 is a schematic view showing the one-way valve of FIGS. 16-18implanted in the side wall of a blood vessel;

FIGS. 20-24 are schematic views which show alternative valve elementswhich may be used with the novel one-way valve of the present invention;

FIGS. 25 and 26 are schematic views which show alternative connectionelements which may be used with the novel one-way valve of the presentinvention;

FIGS. 27 and 28 are schematic views showing another novel one-way valveformed in accordance with the present invention;

FIGS. 29-36 are schematic views showing another novel delivery systemwhich may be used to deliver a novel one-way valve (e.g., the novelone-way valve of FIGS. 27 and 28 ) to an internal anatomical site;

FIGS. 37-42 are schematic views showing how a novel one-way valve (e.g.,the novel one-way valve of FIGS. 27 and 28 ) formed in accordance withthe present invention may be implanted into the side wall of a bloodvessel via an “endovascular approach” using the novel delivery system ofFIGS. 29-36 ;

FIGS. 43-45 are schematic views showing a novel one-way valve formed inaccordance with the present invention which is configured forfluidically connecting a first body cavity to a second body cavity;

FIGS. 46-48 are schematic views showing how a novel one-way valve (e.g.,the novel one-way valve of FIGS. 43-45 ) formed in accordance with thepresent invention may be implanted into the body of a patient so as tofluidically connect the plural cavity with the abdominal cavity; and

FIG. 49 is a schematic view showing how a novel one-way valve (e.g., thenovel one-way valve of FIGS. 43-45 ) formed in accordance with thepresent invention may be implanted into the body of a patient so as tofluidically connect the pleural cavity with a venous blood vessel.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

The present invention comprises the provision and use of a novelimplantable one-way valve, and a novel method for treating a patientusing the novel implantable one-way valve, so as to provide a directconnection between the abdominal cavity and the venous system of thepatient.

The present invention also comprises the provision and use of a novelimplantable one-way valve, and a novel method for treating a patientusing the novel implantable one-way valve, so as to provide a directconnection between a first body cavity (e.g., the pleural cavity) and asecond body cavity (e.g., the abdominal cavity).

And the present invention further comprises the provision and use of anovel implantable one-way valve, and a novel method for treating apatient using the novel implantable one-way valve, so as to provide adirect connection between a first body cavity (e.g., the pleural cavity)and the venous system of the patient.

For purposes of the present disclosure, the terms “proximal” and“distal” are used in the context of the fluid flow through the anatomy,i.e., the “proximal” direction is the direction towards the abdominalcavity (or first body cavity) containing the ascetic fluid (or otherbody fluid) and the “distal” direction is the direction towards theinterior of the blood vessel (or second body cavity) which is to receivethe ascetic fluid (or other body fluid). Thus, for purposes of thepresent disclosure, the “proximal” end of the novel implantable one-wayvalve (see below) refers to the end of the novel implantable one-wayvalve directed toward the abdominal cavity (or first body cavity)containing the ascetic fluid (or other body fluid) and the “distal” endof the novel implantable one-way valve (see below) refers to the end ofthe novel implantable one-way valve directed toward the blood vessel (orsecond body cavity) which is to receive the ascetic fluid (or other bodyfluid).

Novel One-Way Valve

In one preferred form of the invention, and looking now at FIGS. 5-8 ,there is shown a novel implantable one-way valve 25. One-way valve 25generally comprises a body 30, a valve element 35, a proximal connectionelement 40 and a distal connection element 45.

More particularly, valve body 30 generally comprises a tube 50 having aproximal end 55, a distal end 60, and a lumen 65 extending therebetween.Lumen 65 comprises an inlet 70 disposed at proximal end 55 of tube 50and an outlet 75 disposed at distal end 60 of tube 50.

In a preferred form of the present invention, tube 50 (and hence, lumen65) comprises a generally circular cross-section and is radiallycompressible in order to aid in implantation of one-way valve 25 into ablood vessel, as will hereinafter be discussed in further detail. Itshould be appreciated that in a preferred form of the invention, thelength of tube 50 can be selected such that the length of tube 50 is atleast equal to the thickness of the wall of the blood vessel into whichone-way valve 25 is to be implanted, plus the thickness of interstitialtissue (disposed between the wall of the blood vessel and the peritoneallayer) which tube 50 will need to extend through in order to reach thewall of the blood vessel, plus the thickness of the peritoneal layerwhich tube 50 will need to extend through. Furthermore, if desired, thediameter of tube 50 can be selected such that tube 50 will comprise adiameter smaller than the diameter of the blood vessel into whichone-way valve 25 is to be implanted.

Valve element 35 is disposed within lumen 65 of tube 50, intermediateproximal end 55 of tube 50 and distal end 60 of tube 50. In onepreferred form of the invention, valve element 35 comprises a one-way,slit-type valve such that fluid may enter into inlet 70, pass throughthe proximal portion of lumen 65, pass through valve element 35, passthrough the distal portion of lumen 65 and exit out of outlet 75, butwhich does not allow fluid to flow in the opposite direction (i.e., fromthe blood vessel, through valve element 35 and into the abdominalcavity). As a result, when one-way valve 25 is implanted into a bloodvessel (e.g., a vein) in the region of the abdominal cavity such thatinlet 70 is open to ascetic fluid within the abdominal cavity and outlet75 is open to the interior of the blood vessel, ascetic fluid can flowfrom the abdominal cavity, through one-way valve 25 and into the vein,but fluid cannot flow in the opposite direction.

It should be appreciated that valve element 35 is preferably configuredsuch that valve element 35 is “closed” (i.e., does not permit fluid toflow) until the pressure differential between (i) the pressure of thefluid entering inlet 70, and (ii) the pressure of the fluid enteringoutlet 75, rises above a pre-determined threshold. By way of example butnot limitation, valve element 35 may be configured to “open” (i.e.,allow fluid to flow from inlet 70, through valve element 35 and out ofoutlet 75) when the pressure differential on the two sides of the valveelement is less than 10 mmHg and, more preferably, when the pressuredifferential is between 2 mmHg and 5 mmHg.

Proximal connection element 40 is preferably mounted to proximal end 55of tube 50 of valve body 30, and distal connection element 45 ispreferably mounted to distal end 60 of tube 50 of valve body 30.Proximal connection element 40 and distal connection element 45 arepreferably spaced apart from one another such that when one-way valve 25is deployed at an internal site (e.g., across the wall of a blood vesselsuch as a vein, plus any interstitial tissue, plus the peritoneallayer), the blood vessel wall (plus interstitial tissue, plus theperitoneal layer) is captured between proximal connection element 40 anddistal connection element 45, whereby to anchor one-way valve 25 inplace within the wall of the blood vessel. To this end, the distancebetween proximal connection element 40 and distal connection element 45is preferably equal to the thickness of the vessel wall to be spanned byone-way valve 25, plus any intervening tissue through which the deployedone-way valve 25 will pass (e.g., interstitial tissue, peritoneal layer,etc.).

Proximal connection element 40 preferably comprises a plurality of legs80 extending radially outward from tube 50 and terminating in aplurality of distally-directed contact surfaces 85. Legs 80 arepreferably spring-biased such that they can be radially constrained whenone-way valve 25 is being delivered to an internal anatomical site(e.g., via a delivery sheath), and thereafter spring outward (e.g., whenthe delivery sheath is removed) such that legs 80 and/ordistally-directed contact surfaces 85 engage the wall of the bloodvessel (or the intervening tissue), whereby to anchor proximalconnection element 40 (and hence, one-way valve 25) in position, as willhereinafter be discussed in further detail.

Distal connection element 45 preferably comprises a plurality of legs 90extending radially outward from tube 50 and terminating in a pluralityof proximally-directed contact surfaces 95. Legs 90 are preferablyspring-biased such that they can be radially constrained when one-wayvalve 25 is being delivered to an internal anatomical site (e.g., via adelivery sheath), and thereafter spring outward (e.g., when the deliverysheath is removed) such that legs 90 and/or proximally-directed contactsurfaces 95 engage the wall of the blood vessel (or the interveningtissue), whereby to anchor distal connection element 45 (and hence,one-way valve 25) in position, as will hereinafter be discussed infurther detail.

In one preferred form of the invention, the distal end of one-way valve25 (i.e., the portions of the one-way valve which extend into theinterior of the blood vessel) are formed so as to be as smooth aspossible so as to minimize thrombus formation.

Although one-way valve 25 is depicted in FIGS. 5-8 as having twoconnection elements (i.e., a proximal connection element 40 and a distalconnection element 45), it should be appreciated that, if desired,one-way valve 25 may comprise only a single connection element. By wayof example but not limitation, distal connection element 45 may beomitted. In this form of the invention, proximal connection element 40is configured to anchor one-way valve 25 in the blood vessel (e.g.,proximal connection element 40 might comprise a sewing ring for suturingproximal connection element 40 to the wall of the blood vessel or theintervening tissue). This may be advantageous in some applications,inasmuch as distal connection element 45 would otherwise be disposedwithin the interior of a blood vessel, and the omission of distalconnection element 45 (i.e., legs 95 of distal connection element 45),which is typically disposed within the interior of the blood vessel, canminimize the incidence of thrombosis at the site of implantation.

Exemplary Use of One-Way Valve 25

In use, and looking now at FIG. 9 , one-way valve 25 is preferablyimplanted into the peritoneum/interstitium (sometimes hereinafterreferred to as the “peritoneal layer” and the “interstitial tissue” or“interstitial layer”, respectively) and the wall of a blood vessel 100(e.g., the vena cava, the vena iliaca, etc.) such that inlet 70 ofone-way valve 25 is in fluid communication with the abdominal cavity 105(e.g., such that inlet 70 is in fluid communication with the asceticfluid), and outlet 75 is in fluid communication with the interior ofblood vessel 100. Proximal connection element 40 contacts the outer wallof blood vessel 100 (or contacts the intervening tissue, e.g., theperitoneal layer and/or interstitial tissue), and distal connectionelement 45 contacts the inner wall of blood vessel 100, therebyanchoring one-way valve 25 within the wall of blood vessel 100 such thatone-way valve 25 spans the blood vessel wall (and any interveningtissue) and provides a one-way fluid pathway from abdominal cavity 105,through tube 50 (and through valve element 35) into the interior ofblood vessel 100.

As a result, fluid is able to flow from abdominal cavity 105, into inlet70 of one-way valve 25, through valve element 35 and out of outlet 75 ofone-way valve 25, into the interior of blood vessel 100.

As will hereinafter be discussed in further detail, a delivery systemmay be provided for implanting the one-way valve into the wall of theblood vessel.

As will also hereinafter be discussed in further detail, one-way valve25 may be implanted using an “abdominal approach” in which the one-wayvalve is advanced from the abdominal cavity, through the wall of theblood vessel, and into the lumen of the blood vessel. Alternatively,one-way valve 25 may be implanted using an “endoluminal approach” inwhich the one-way valve is advanced from the lumen of the blood vessel,through the wall of the blood vessel, and into the abdominal cavity.

Delivery System for Delivering and Deploying One-Way Valve 25

As discussed above, one-way valve 25 is configured to be implanted intothe side wall of a blood vessel (e.g., a vein) at an internal anatomicalsite in order to facilitate treatment of ascites. To this end, it isdesirable to provide a novel delivery system for delivering one-wayvalve 25 to an internal anatomical site, and for deploying one-way valve25 into the side wall of the blood vessel.

Looking next at FIG. 10 , there is shown a novel delivery system 110.Delivery system 110 generally comprises a puncture device 115, aguidewire 120, a deployment catheter 125 and a delivery sheath 130. Alsoshown in FIG. 10 is one-way valve 25 loaded on guidewire 120 anddisposed within deployment catheter 125.

More particularly, puncture device 115 preferably comprises an elongatedshaft having a sharp distal end which may be used to penetrate throughtissue (e.g., through the peritoneal layer, through interstitial tissue,through the wall of a blood vessel, etc.).

Guidewire 120 comprises a flexible guidewire of the sort well known inthe art which may be used to guide one-way valve 25 to an internal site,as will hereinafter be discussed in further detail.

Deployment catheter 125 generally comprises a tube having an open distalend, an open proximal end, and a lumen extending therebetween. The lumenof deployment catheter 125 is sized so as to hold one-way valve 25 in aradially-contracted condition, e.g., with legs 80 of proximal connectionelement 40 and legs 90 of distal connection element 45 being heldparallel to valve body 30, whereby to provide a reduced profile fordelivery of one-way valve 25 to an internal anatomical site, as willhereinafter be discussed in further detail.

Delivery sheath 130 generally comprises a tube having an open distalend, an open proximal end, and a lumen extending therebetween. Deliverysheath 130 is sized so as to fit over deployment catheter 125, wherebyto protect deployment catheter 125 and one-way valve 25 during deliveryto an internal anatomical site, as will hereinafter be discussed infurther detail.

Method of Implanting and Deploying One-Way Valve 25

As discussed above, one-way valve 25 is intended to be deployed in theside wall of a blood vessel proximate to the abdominal cavity such thatfluid can flow from the abdominal cavity, through one-way valve 25, andinto the interior of the blood vessel. One-way valve 25 may be deployedat an internal anatomical site using various methods (e.g., opensurgery, percutaneous deployment, endoluminal deployment, etc.) orcombinations thereof.

By way of example but not limitation, and looking now at FIGS. 11-13 ,one-way valve 25 may be implanted using an “abdominal approach” in whichthe one-way valve is advanced from the abdominal cavity, through thewall of the blood vessel, and into the lumen of the blood vessel.

By way of example but not limitation, in order to prepare the internalsite for implantation of one-way valve 25, the surgeon first extractsthe ascetic fluid from the abdominal cavity (e.g., using a syringe, acollection bag, suction, etc.). The abdominal cavity is then rinsed(e.g., with saline) and drained (e.g., using a syringe, collection bag,suction, etc.). If desired, one or more access ports (e.g., accesscannulas) may be inserted into the patient's abdomen (i.e., through theskin) in order to provide the surgeon with access to the abdominalcavity and to visualize/access the blood vessel into which one-way valve25 is to be implanted. By way of example but not limitation, the surgeonmay use the access ports to insert optical devices, instruments, etc.into the abdominal cavity in order to help the surgeon locate the bloodvessel (e.g., the inferior vena cava, the common iliac veins, etc.) intowhich one-way valve 25 is to be implanted.

Puncture device 115 of delivery system 110 may be advanced from theabdominal cavity (e.g., through delivery sheath 130) so that it passesthrough the side wall of the blood vessel so as to form a hole in theside wall of the blood vessel, and then deployment catheter 125 (passingthrough delivery sheath 130) may be used to bring one-way valve 25 (withits proximal connection element 40 and its distal connection element 45in their radially contracted conditions) through the hole formed in theside wall of the blood vessel. Then deployment catheter 125 is removedso that proximal connection element 40 and distal connection element 45assume their radially expanded conditions, whereby to secure one-wayvalve 25 in the side wall of the blood vessel. Delivery sheath 130 maythen be removed. At the conclusion of the procedure, one-way valve 25 issecurely anchored within the side wall of the blood vessel (e.g., theinferior vena cava), held in position by proximal connection element 40and distal connection element 45. Inlet 70 of tube 50 of one-way valve25 is fluidically connected to the abdominal cavity and outlet 75 oftube 50 of one-way valve 25 is fluidically connected to the blood vessel(e.g., the interior of the inferior vena cava). As a result, fluid(e.g., fluid resulting from ascites) is able to flow from the abdominalcavity, into inlet 70 of tube 50, along lumen 65 of tube 50, throughvalve element 35 and out outlet 75 of tube 50 into the interior of theblood vessel (e.g., the interior of the inferior vena cava), but fluidis unable to flow in the opposite direction. Thus, fluid can exit theabdominal cavity and enter the blood vessel without the need for a longcatheter or the need for external access to the abdominal cavity.

Alternatively, and looking now at FIGS. 14 and 15 , one-way valve 25 maybe implanted using an “endoluminal approach”. In a preferred form of thepresent invention, one-way valve 25 is implanted using an endovascularapproach in which the one-way valve is advanced from the lumen of theblood vessel, through the wall of the blood vessel, and into theabdominal cavity.

By way of example but not limitation, in order to prepare the internalsite for implantation of one-way valve 25, the surgeon first extractsthe ascetic fluid from the abdominal cavity (e.g., using a syringe, acollection bag, suction, etc.). If desired, fluid may also be drainedfrom the abdominal cavity using novel delivery system 110 (e.g., bydraining the abdominal cavity using deployment catheter 125 and/ordelivery sheath 130). The abdominal cavity is then rinsed (e.g., withsaline) and drained (e.g., using a syringe, collection bag, suction,etc.). If desired, one or more access ports (e.g., access cannulas) maybe inserted into the patient's abdomen (i.e., through the skin) in orderto provide the surgeon with access to the abdominal cavity and tovisualize/access the blood vessel into which one-way valve 25 is to beimplanted, however, it should be appreciated that such access ports inthe patient's abdomen are generally unnecessary when using anendovascular approach to implant one-way valve 25. By way of example butnot limitation, the surgeon may use the access ports to insert opticaldevices, instruments, etc. into the abdominal cavity in order to helpthe surgeon locate the blood vessel (e.g., the inferior vena cava, thecommon iliac veins, etc.) into which one-way valve 25 is to beimplanted.

After the surgeon has located a suitable blood vessel for implantationand identified a suitable implantation site (i.e., a suitable bloodvessel for receiving one-way valve 25 proximate to the abdominalcavity), puncture device 115 is used to puncture the skin of the patientso as to access the interior of a blood vessel. In a preferred form ofthe invention, access to the vasculature is made by puncturing thejugular vein (FIG. 15A) using a puncture device 115 and then the one-wayvalve is advanced to the selected internal site endoluminally.Alternatively, access to the vasculature may be achieved by puncturingthe subclavian vein (also known as the vena subclavia) and then one-wayvalve is advanced to the internal site endoluminally. In still anotherform of the invention, access to the vasculature is made via the venafemoralis (FIG. 15B) at a location remote from the patient's abdomen(e.g., the thigh, groin, etc.) in order to allow endoluminal advancementof one-way valve 25 to the selected internal anatomical site. Guidewire120 is then inserted into the blood vessel (e.g., the jugular vein) andadvanced through the puncture site endoluminally until the guidewire isdisposed at the internal anatomical site (e.g., the desired locationwithin the inferior vena cava).

Delivery sheath 130 is then advanced to the internal anatomical site bypassing delivery sheath 130 over guidewire 120.

Puncture device 115 is then advanced to the internal anatomical site andused to puncture the side wall of the blood vessel (e.g., the distalinferior vena cava, distal to the inflow of the renal veins so as toavoid damaging the duodenum) at the internal anatomical site whereone-way valve 25 is to be implanted, and to puncture any interveningtissue, whereby to create a path between the interior of the bloodvessel and the abdominal cavity.

Deployment catheter 125, carrying one-way valve 25 within the lumen ofdeployment catheter 125, is then advanced to the internal anatomicalsite through the lumen of delivery sheath 130, and deployment catheter125 is advanced through the puncture site in the side wall of the bloodvessel (e.g., the inferior vena cava) and into the abdominal cavity. Itshould be appreciated that at this time, one-way valve 25 is disposedjust inside the distal end of deployment catheter 125 (or,alternatively, one-way valve 25 may be advanced to a position justinside the distal end of deployment catheter 125). When one-way valve 25is disposed in the desired position, the surgeon deploys one-way valveeither by (i) pushing one-way valve 25 such that proximal connectionelement 40 is advanced out of the lumen of deployment catheter 125, or(ii) by withdrawing deployment catheter 125 such that proximalconnection element 40 is freed from the lumen of deployment catheter125, or (iii) by a combination of the foregoing techniques. As theradially-constricted legs 80 of proximal connection element 40 arereleased from deployment catheter 125, legs 80 expand radially outward,with distally-directed contact surfaces 85 contacting the outer wall ofthe blood vessel (or the interstitial tissue covering the outer wall ofthe blood vessel).

Next, deployment catheter 125 is withdrawn further until distalconnection element 45, which is disposed within the interior of theblood vessel (e.g., the interior of the inferior vena cava), isuncovered. As the radially-constricted legs 90 of distal connectionelement 45 are released from deployment catheter 125, legs 90 expandradially outward into their radially-expanded configuration, withproximally-directed contact surfaces 95 contacting the inner wall of theblood vessel. At this point, one-way valve 25 is locked in positionwithin the side wall of the blood vessel.

Finally, deployment catheter 125 is withdrawn so as to remove thedeployment catheter from the patient's body, and then guidewire 120 anddelivery sheath 130 are also withdrawn from the patient's body.

At the conclusion of the procedure, one-way valve 25 is securelyanchored within the side wall of the blood vessel (e.g., the inferiorvena cava), held in position by proximal connection element 40 anddistal connection element 45. Inlet 70 of tube 50 of one-way valve 25 isfluidically connected to the abdominal cavity and outlet 75 of tube 50of one-way valve 25 is fluidically connected to the blood vessel (e.g.,the interior of the inferior vena cava). As a result, fluid (e.g., fluidresulting from ascites) is able to flow from the abdominal cavity, intoinlet 70 of tube 50, along lumen 65 of tube 50, through valve element 35and out outlet 75 of tube 50 into the interior of the blood vessel(e.g., the interior of the inferior vena cava), but fluid is unable toflow in the opposite direction. Thus, fluid can exit the abdominalcavity and enter the blood vessel without the need for a long catheteror the need for external access to the abdominal cavity.

Alternative One-Way Valve

Looking now at FIGS. 16-19 , there is shown another one-way valve 25Aformed in accordance with the present invention. One-way valve 25A issubstantially identical to the one-way valve 25 discussed above,however, proximal connection element 40 and distal connection element 45are replaced by proximal connection element 40A and distal connectionelement 45A, respectively.

More particularly, one-way valve 25A generally comprises a body 30A, avalve element 35A, a proximal connection element 40A and a distalconnection element 45A.

Body 30A generally comprises a tube 50A having a proximal end 55A, adistal end 60A, and a lumen 65A extending therebetween. Lumen 65Acomprises an inlet 70A disposed at proximal end 55A of tube 50A and anoutlet 75A disposed at distal end 60A of tube 50A.

In one form of the present invention, tube 50A (and hence, lumen 65A)comprises a generally circular cross-section and is radiallycompressible in order to aid in implantation of one-way valve 25A into ablood vessel, as will hereinafter be discussed in further detail. Itshould be appreciated that in a preferred form of the invention, thelength of tube 50A can be selected such that the length of tube 50A isat least equal to the thickness of the wall of the blood vessel intowhich one-way valve 25A is to be implanted, plus the thickness ofinterstitial tissue which tube 50A will need to extend through in orderto reach the wall of the blood vessel, plus the thickness of theperitoneal layer which tube 50A will need to extend through.Furthermore, if desired, the diameter of tube 50A can be selected suchthat tube 50A will comprise a diameter smaller than the diameter of theblood vessel into which one-way valve 25A is to be implanted.

Valve element 35A is disposed within lumen 65A of tube 50A, intermediateproximal end 55A and distal end 60A of tube 50A. In one form of theinvention, valve element 35A comprises a one-way slit-type valve whichallows fluid to enter into inlet 70A, pass through the proximal portionof lumen 65A, pass through valve element 35A, pass through the distalportion of lumen 65A and exit lumen 65A out of outlet 75A, but whichdoes not allow fluid to flow in the opposite direction (i.e., from theblood vessel, through valve element 35A and into the abdominal cavity).As a result, when one-way valve 25A is implanted into a blood vessel(e.g., a vein) in the region of the abdominal cavity such that inlet 70Ais open to fluid within the abdominal cavity and outlet 75A is open tothe interior of a blood vessel, fluid can flow from the abdominalcavity, through one-way valve 25A and into the blood vessel, but fluidcannot flow in the opposite direction.

It should be appreciated that valve element 35A is preferably configuredsuch that valve element 35A is “closed” (i.e., does not permit fluid toflow) until the pressure differential between (i) the pressure of thefluid entering inlet 70A, and (ii) the pressure of the fluid enteringoutlet 75A, rises above a pre-determined threshold. By way of examplebut not limitation, valve element 35A may be configured to “open” (i.e.,allow fluid to flow from inlet 70A, through valve element 35A and out ofoutlet 75A) when the pressure differential on the two sides of the valveelement is less than 10 mmHg and, more preferably, when the pressuredifferential is between 2 mmHg and 5 mmHg.

Proximal connection element 40A is preferably mounted to proximal end55A of tube 50A of valve body 30A, and distal connection element 45A ispreferably mounted to distal end 60A of tube 50A of valve body 30A.Proximal connection element 40A and distal connection element 45A arepreferably spaced apart from one another such that when one-way valve25A is deployed at an internal site (e.g., across the wall of a bloodvessel such as a vein), the blood vessel wall is captured betweenproximal connection element 40A and distal connection element 45A,whereby to anchor one-way valve 25A in place within the wall of theblood vessel. To this end, the distance between proximal connectionelement 40A and distal connection element 45A is preferably equal to thethickness of the vessel wall to be spanned by one-way valve 25A plus anyintervening tissue through which the deployed one-way valve 25A willpass (e.g., interstitial tissue, peritoneal layer, etc.).

Proximal connection element 40A is similar to the aforementionedproximal connection element 40, however, proximal connection element 40Acomprises a radially expandable mesh basket 155, rather than a pluralityof legs 80, for engaging the outer wall of the blood vessel. Moreparticularly, basket 155 of proximal connection element 40A ispreferably spring-biased such that basket 155 will automatically deployradially outward when proximal connection element 40A is unconstrained(i.e., released from deployment catheter 125 in the manner discussedabove).

Distal connection element 45A is similar to the aforementioned distalconnection element 45, however, distal connection element 45A comprisesa radially expandable mesh basket 160, rather than a plurality of legs80, for engaging the inner wall of the blood vessel. More particularly,basket 160 of distal connection element 45A is preferably spring-biasedsuch that basket 160 will automatically deploy radially outward whendistal connection element 45A is unconstrained (i.e., released fromdeployment catheter 125 in the manner discussed above).

Although one-way valve 25A is depicted in FIGS. 16-19 as having twoconnection elements (i.e., a proximal connection element 40A and adistal connection element 45A), it should be appreciated that, ifdesired, one-way valve 25A may comprise only a single connectionelement. By way of example but not limitation, distal connection element45A may be omitted. In this form of the invention, proximal connectionelement 40A is configured to anchor one-way valve 25A in the bloodvessel (e.g., proximal connection element 40A might comprise a sewingring for suturing proximal connection element 40A to the wall of theblood vessel or the intervening tissue). This may be advantageous insome applications, inasmuch as distal connection element 45A wouldotherwise be disposed within the interior of a blood vessel, and theomission of distal connection element 45A (i.e., radially expandablemesh basket 160 of distal connection element 45A), which is typicallydisposed within the interior of the blood vessel, can minimize theincidence of thrombosis at the site of implantation.

Alternative Valve Elements

In the foregoing descriptions, valve elements 35/35A are shown anddescribed as slit-type valves which automatically open in order to allowfluid flow in a single, pre-determined direction (i.e., from theabdominal cavity, through valve element 35/35A and out to the interiorof the blood vessel) when the pressure differential across the valveelement exceeds a pre-determined threshold.

However, it should be appreciated that valve elements 35/35A may beprovided in various other configurations if desired.

By way of example but not limitation, and looking now at FIG. 20 , thereis shown a valve element 35B which comprises a flexible flap 165 whichpivots away from a stop 170 when the pressure differential across thevalve exceeds a predetermined threshold, whereby to allow fluid flow,but which seats against stop 170 when the pressure differential acrossthe valve falls below a predetermined threshold. In this way, valveelement 35B provides one-way flow through lumen 65 of one-way valve 25.

By way of further example but not limitation, and looking now at FIG. 21, there is shown a valve element 35C which comprises a spring-biasedplunger 175 which is configured to move longitudinally away from a stop180 when the pressure differential across the valve exceeds apredetermined threshold, whereby to allow fluid flow, but which seatsagainst stop 180 when the pressure differential across the valve fallsbelow a predetermined threshold. In this way, valve element 35C providesone-way flow through lumen 65 of one-way valve 25.

By way of further example but not limitation, and looking now at FIG. 22, there is shown a valve element 35D which comprises a ball 185 which isconfigured to move longitudinally within a cage 190, so that ball 185can move away from a stop 195 when the pressure differential across thevalve exceeds a predetermined threshold, whereby to allow fluid flow,but which seats against stop 195 when the pressure differential acrossthe valve falls below a predetermined threshold. In this way, valveelement 35D provides one-way flow through lumen 65 of one-way valve 25.

By way of further example but not limitation, and looking now at FIG. 23, there is shown a valve element 35E which comprises a disc 200 which isconfigured to move longitudinally within a chamber 205, so that disc 200can move away from a stop 210 when the pressure differential across thevalve exceeds a predetermined threshold, whereby to allow fluid flow,but which seats against stop 210 when the pressure differential acrossthe valve falls below a predetermined threshold. In this way, valveelement 35E provides one-way flow through lumen 65 of one-way valve 25.

By way of further example but not limitation, and looking now at FIG. 24, there is shown a valve element 35F which comprises a wheel 215 whichis configured to rotate in one direction within a chamber 220 when thepressure differential across the valve exceeds a predeterminedthreshold, whereby to allow fluid flow through lumen 65 of one-way valve25, but which is prevented from rotating in the opposite directionwithin the chamber by a stop 225 when the pressure differential acrossthe valve falls below a predetermined threshold, whereby to preventfluid flow through lumen 65 of one-way valve 25. In this way, valveelement 35F provides one-way flow through lumen 65 of one-way valve 25.

It will be appreciated by those skilled in the art that still otherconfigurations are possible for valve element 35.

Alternative Connection Elements

In the foregoing description, one-way valve 25 is described as beinghaving a body 50 which extends through the wall of a blood vessel, andhaving a proximal connection element 40 contacting the outside surfaceof the blood vessel, and a distal connection element 45 contacting theinside surface of the blood vessel, and with connection elements 40, 45being spaced apart from one another such that when one-way valve 25 isdeployed across the wall of a blood vessel, the blood vessel wall iscaptured between proximal connection element 40 and distal connectionelement 45, whereby to anchor one-way valve 25 in place.

And in the foregoing description, proximal connection element 40 wasdescribed as comprising a plurality of legs 80 terminating in aplurality of distally-directed contact surfaces 85, and distalconnection element 45 was described as comprising a plurality of legs 90terminating in a plurality of proximally-directed contact surfaces 95.

However, it should be appreciated that it is possible to anchor one-wayvalve 25 in place across the wall of a blood vessel using various otherconfigurations of connection elements.

By way of example but not limitation, and looking now at FIG. 25 , inanother form of the invention, there is shown a one-way valve 25B havinga body 30B, wherein body 30B is in the form of an expandable stent 50B,and having a valve element 35 disposed within body 30B. In this form ofthe invention, stent 50B is capable of expanding laterally, such thatone end of stent 50B forms proximal connection element 40B and the otherend of stent 50B forms distal connection element 45B, with proximalconnection element 40B contacting the outside surface of the bloodvessel and distal connection element 45B contacting the inside surfaceof the blood vessel, whereby to anchor one-way valve 25B in place.Expandable stent 50B is preferably a covered stent.

By way of further example but not limitation, and looking now at FIG. 26, in another form of the invention, there is shown a one-way valve 25Chaving a body 30C, wherein body 30C is in the form of a shaft 50C, andhaving a valve element 35 disposed within shaft 50C. In this form of theinvention, one end of shaft 50C comprises barbs 230 so as to formproximal connection element 40C and the other end of shaft 50C comprisesa flange 235 so as to form distal connection element 45C, with proximalconnection element 40C engaging the wall of the blood vessel and distalconnection element 45C contacting the inside surface of the bloodvessel, whereby to anchor one-way valve 25C in place.

It will be appreciated by those skilled in the art that still otherconfigurations are possible for connection elements 40, 45.

Alternative One-Way Valve

Looking now at FIG. 27 , there is shown another one-way valve 300 formedin accordance with the present invention. One-way valve 300 is generallysimilar to the one-way valves 25, 25A discussed above, however, thevalve element is disposed on the distal end of the one-way valve so thatthe valve element extends into the blood vessel, as will hereinafter bediscussed in further detail.

More particularly, one-way valve 300 generally comprises a body 305, avalve element 310, a proximal connection element 315 and a distalconnection element 320.

Body 305 generally comprises a tube 325 having a proximal end 330, adistal end 335, and a lumen 340 extending therebetween. Lumen 340comprises an inlet 345 disposed at proximal end 330 of tube 325 and anoutlet 350 disposed at distal end 335 of tube 325.

In one form of the present invention, tube 325 (and hence, lumen 340)comprises a generally circular cross-section and isradially-compressible in order to aid in implantation of one-way valve300 into a blood vessel, as will hereinafter be discussed in furtherdetail. It should be appreciated that in a preferred form of theinvention, the length of tube 325 can be selected such that the lengthof tube 325 is at least equal to the thickness of the wall of the bloodvessel into which one-way valve 300 is to be implanted, plus thethickness of interstitial tissue which tube 325 will need to extendthrough. Furthermore, if desired, the diameter of tube 325 can beselected such that tube 325 will comprise a diameter smaller than thediameter of the blood vessel into which one-way valve 300 is to beimplanted.

Valve element 310 preferably comprises a flexible length of tubing 355having a proximal end 360, a distal end 365 and a passageway 370extending therebetween. Proximal end 360 of tubing 355 comprises a valveelement inlet 362 in fluid communication with passageway 370. Tubing 355is mounted to outlet 350 of lumen 340 such that valve element inlet 362(and hence, passageway 370) is fluidically connected to lumen 340.Distal end 365 of tubing 355 comprises a valve element outlet 367 influid communication with passageway 370. Passageway 370 of tubing 355 ispreferably configured such that valve element outlet 367 of passageway370 is closed (i.e., tubing 355 is flattened) when valve element 310 isin its resting state such that fluid cannot enter into, or exit out of,valve element outlet 367, i.e., such that valve element 310 is “closed”.When the pressure differential between (i) the pressure of the fluidentering valve element inlet 362 (which is equal to the fluid pressureentering inlet 345 of lumen 340), and (ii) the pressure of fluidentering valve element outlet 367 of valve element 310 rises above apre-determined threshold, valve element outlet 367 “opens”, whereby topermit fluid to flow from inlet 345, through lumen 340, through outlet350, through passageway 370 of tubing 355 (i.e., through valve element310) and out of valve element outlet 367 such that the fluid exits outof one-way valve 300 and into the interior of the blood vessel. By wayof example but not limitation, valve element 310 may be configured to“open” (i.e., allow fluid to flow from inlet 345, though lumen 340,through passageway 370 and out valve element outlet 367 of passageway370) when the pressure differential on the two sides of the valveelement is less than 10 mmHg and, more preferably, when the pressuredifferential is between 2 mmHg and 5 mmHg. It should be appreciated thatin this form of the invention, valve element 310 generally comprises aone-way slit-type valve which allows fluid to enter inlet 345, passthrough lumen 340, pass through outlet 350 and into passageway 370 oftubing 355 and pass out through valve element outlet 367, but which doesnot allow fluid to flow in the opposite direction (i.e., from the bloodvessel, through valve element 310 and into the abdominal cavity). As aresult, when one-way valve 300 is implanted into a blood vessel (e.g., avein) in the region of the abdominal cavity such that inlet 345 is opento fluid within the abdominal cavity and valve element outlet 367 ofvalve element 310 is open to the interior of a blood vessel, fluid canflow from the abdominal cavity, through one-way valve 300 and into theblood vessel, but fluid cannot flow in the opposite direction.

In a preferred form of the present invention, tubing 355 of valveelement 310 is curved so as to be disposed generally transverse to thelongitudinal axis of lumen 340 of body 305 when one-way valve 300 isimplanted into the side wall of a blood vessel, and so as to extendalong a distance of the blood vessel into which one-way valve 300 isimplanted. If desired, tubing 355 of valve element 310 may comprise asmooth outer surface (e.g., Teflon) in order to minimize thrombusformation.

It should also be appreciated that, if desired, an additional valveelement (e.g., valve element 35,35A etc.) may be disposed within lumen340 of body 305 of one-way valve 300 in addition to (or in lieu of)valve element 310. Alternatively, a valve element (e.g., valve element35,35A, etc.) may be disposed within passageway 370 of tubing 355.

Proximal connection element 315 is preferably mounted to proximal end330 of tube 325 of valve body 305, and distal connection element 320 ispreferably mounted to distal end 335 of tube 325 of valve body 305.Proximal connection element 315 and distal connection element 320 arepreferably spaced apart from one another such that when one-way valve300 is deployed at an internal site (e.g., across the wall of a bloodvessel such as a vein), the blood vessel wall is captured betweenproximal connection element 315 and distal connection element 320,whereby to anchor one-way valve 300 in place within the wall of theblood vessel. To this end, the distance between proximal connectionelement 315 and distal connection element 320 is preferably equal to thethickness of the vessel wall to be spanned by one-way valve 300 plus anyintervening tissue through which the deployed one-way valve 300 willpass (e.g., interstitial tissue, peritoneal layer, etc.).

Proximal connection element 315 preferably comprises a plurality of legs375 extending radially outward from tube 325 and terminating in aplurality of distally-directed contact surfaces 380. Legs 375 arepreferably spring-biased such that they can be radially constrained whenone-way valve 300 is being delivered to an internal anatomical site(e.g., via a delivery sheath), and thereafter spring outward (e.g., whenthe deliver sheath is removed) such that legs 375 and/ordistally-directed contact surfaces 380 engage the wall of the bloodvessel (or the intervening tissue), whereby to anchor proximalconnection element 315 (and hence, one-way valve 300) in position, aswill hereinafter be discussed in further detail. In a preferredembodiment of the present invention, one-way valve 300 comprises fourlegs 375, however, it should be appreciated that one-way valve 300 maycomprise a greater number of legs 375 (or a lesser number of legs 375)without departing from the scope of the present invention.

Distal connection element 320 preferably comprises a plurality of legs385 extending radially outward from tube 325 and terminating in aplurality of proximally-directed contact surfaces 390. Legs 385 arepreferably spring-biased such that they can be radially constrained whenone-way valve 300 is being delivered to an internal anatomical site(e.g., via a delivery sheath), and thereafter spring outward (e.g., whenthe delivery sheath is removed) such that legs 385 and/orproximally-directed contact surfaces 390 engage the wall of the bloodvessel (or the intervening tissue), whereby to anchor distal connectionelement 320 (and hence, one-way valve 300) in position, as willhereinafter be discussed in further detail. In a preferred form of thepresent invention, one-way valve 300 comprises four legs 385, however,it should be appreciated that one-way valve 300 may comprise a greaternumber of legs 385 (or a lesser number of legs 385) without departingfrom the scope of the present invention.

In one preferred form of the invention, the distal end of one-way valve300 (i.e., the portions of the one-way valve which extend into theinterior of the blood vessel) are formed so as to be as smooth aspossible so as to minimize thrombus formation.

Although one-way valve 300 is depicted in FIGS. 27 and 28 as having twoconnection elements (i.e., a proximal connection element 315 and adistal connection element 320), it should be appreciated that, ifdesired, one-way valve 300 may comprise only a single connectionelement. By way of example but not limitation distal connection element320 may be omitted. In this form of the invention, proximal connectionelement 315 is configured to anchor one-way valve 300 in the bloodvessel (e.g., proximal connection element 315 might comprise a sewingring for suturing proximal connection element 315 to the wall of theblood vessel or the intervening tissue). This may be advantageous insome applications, inasmuch as distal connection element 320 wouldotherwise be disposed within the interior of a blood vessel, and theomission of distal connection element 320 (i.e., legs 385 of distalconnection element 320), which is typically disposed within the interiorof the blood vessel, can minimize the incidence of thrombosis at thesite of implantation.

Exemplary Use of One-Way Valve 300

In use, and looking now at FIG. 28 , one-way valve 300 is preferablyimplanted into the peritoneum/interstitium and the wall of a bloodvessel 100 (e.g., the vena cava, the vena iliaca, etc.) such that inlet345 of one-way valve 300 is in fluid communication with the abdominalcavity 105 (e.g., such that inlet 345 is in fluid communication with theascetic fluid), and valve element outlet 367 of valve element 310 is influid communication with the interior of blood vessel 100. Proximalconnection element 315 contacts the outer wall of blood vessel 100 (orcontacts the intervening tissue, e.g., the peritoneal layer and/orinterstitial tissue), and distal connection element 320 contacts theinner wall of blood vessel 100 such that one-way valve 300 spans theblood vessel wall (and any intervening tissue) and provides a one-wayfluid pathway from abdominal cavity 105, through tube 325, through valveelement 310 into the interior of blood vessel 100.

As a result, fluid is able to flow from abdominal cavity 105, into inlet345 of one-way valve 25, through valve element 310 and out valve elementoutlet 367 of tubing 355 of valve element 310, into the interior ofblood vessel 100.

A delivery system (e.g., the aforementioned delivery system 110 oranother novel delivery system, as will hereinafter be discussed) may beprovided for implanting one-way valve 300 into the wall of a bloodvessel.

Although an “endoluminal approach” (e.g., an endovascular approach) ispreferably used to implant one-way valve 300 into the side wall of ablood vessel, if desired, an “abdominal approach” may be used.

Alternative Delivery System

As discussed above, one-way valve 300 (or one-way valve 25, 25A, etc.)is configure to be implanted into the side wall of a blood vessel (e.g.,a vein) at an internal anatomical site in order to facilitate treatmentof ascites. To this end, it is possible to use the novel delivery system110 discussed above in order to deliver one-way valve 300 to theinternal anatomical site and to deploy the one-way valve into the sidewall of the blood vessel. However, in one preferred form of the presentinvention, it is desirable to provide additional control over implantingand deploying one-way valve 300 by utilizing an alternative form ofdelivery system.

To that end, and looking now at FIGS. 29-36 , there is shown analternative novel delivery system 400 formed in accordance with thepresent invention. Delivery System 400 generally comprises a puncturedevice (e.g., the aforementioned puncture device 115), a guidewire 410,a dilator 415, a deployment catheter 420 and a delivery tool 425.

More particularly, the puncture device (not shown in FIGS. 29-36 )preferably comprises an elongated shaft having a sharp distal end whichmay be used to penetrate through tissue (e.g., through the peritoneallayer, through interstitial tissue, through the wall of a blood vessel,etc.). If desired, the puncture device (e.g., puncture device 115) maybe omitted, and a guidewire 410 may be used to penetrate tissue.

Guidewire 410 comprises a flexible guidewire of the sort well known inthe art which may be used to guide the one-way to an internal site, aswill hereinafter be discussed in further detail. If desired, guidewire410 may comprise a pre-curved tip (FIG. 32 ) to facilitate addressingthe side wall of a blood vessel where one-way valve 300 is to beimplanted.

Dilator 415 comprises an elongated tube 430 having a tapered distal end435. In a preferred form of the present invention, tapered distal end435 comprises an opening for receiving guidewire 410 so that dilator 415may be passed over guidewire 410 and advanced to an internal anatomicalsite, as will hereinafter be discussed in further detail.

Deployment catheter 420 generally comprises a tube 440 having an opendistal end 445, an open proximal end 450, and a lumen 455 extendingtherebetween (FIG. 33 ). Lumen 455 of tube 440 is sized so as to holdthe one-way valve in a radially-contracted condition, e.g., with thelegs of the proximal connection element and the legs of the distalconnection element being held parallel to the body of the one-way valve,whereby to provide a reduced profile for delivery of the one-way valveto an internal anatomical site, as will hereinafter be discussed infurther detail. In one preferred form of the present invention,deployment catheter 420 also comprises a spring 460 disposed in thedistal portion of lumen 455 which biases a push rod 465 (which isslidably disposed within lumen 455) proximally, whereby to preventpremature deployment of the one-way valve out of distal end 445 ofdeployment catheter 420, as will hereinafter be discussed in furtherdetail.

Delivery tool 425 comprises a handle 470 and a steerable access sheath475 extending distally from handle 470. Steerable access sheath 475comprises a flexible distal end 480 and a proximal end 485 mounted tohandle 470 with a lumen 490 extending therebetween. A passageway 495(FIG. 30 ) is aligned with lumen 490 and extends through handle 470,opening on the proximal end of handle 470. Passageway 495 (and lumen490) are sized to receive deployment catheter 420, as will hereinafterbe discussed in further detail. In a preferred form of the presentinvention, flexible distal end 480 of steerable access sheath 475 can beselectively articulated using handle 470 by various means, which will beapparent to those skilled in the art in view of the present disclosure.

Method of Implanting and Deploying a One-Way Valve Using Delivery System400

As discussed above, a one-way valve (e.g., one-way valve 25, 25A, 300,etc.) is intended to be deployed in the side wall of a blood vesselproximate to the abdominal cavity such that fluid can flow from theabdominal cavity, through the one-way valve, and into the interior ofthe blood vessel. The one-way valve may be deployed at an internalanatomical site using various methods (e.g., open surgery, percutaneousdeployment, endoluminal deployment, etc.) or combinations thereof.

For clarity of illustration, implantation of one-way valve 300 usingnovel delivery system 400 will be discussed hereinbelow in the contextof an endovascular approach.

By way of example but not limitation, in order to prepare the internalsite for implantation of one-way valve 300, the surgeon first extractsthe ascetic fluid from the abdominal cavity (e.g., using a syringe, acollection bag, suction, etc.). If desired, the ascetic fluid may alsobe drained from the abdominal cavity using an endovascular drain of thesort well known in the art, or by draining the ascetic fluidendovascularly via delivery system 400. The abdominal cavity is thenpreferably rinsed (e.g., with saline) and drained again.

After the surgeon has located a suitable blood vessel for implantationand identified a suitable implantation site (i.e., a suitable bloodvessel for receiving one-way valve 300 proximate to the abdominalcavity), the puncture device (e.g., puncture device 115) is used topuncture the skin of the patient so as to access the interior of a bloodvessel. In a preferred form of the invention, access to the vasculatureis made by puncturing the jugular vein (FIG. 15A) using puncture device115 and then the one-way valve is advanced to the selected internal siteendoluminally. Alternatively, access to the vasculature may be achievedby puncturing the subclavian vein (also known as the vena subclavia) andthen the one-way valve is advanced to the internal site endoluminally.In still another form of the invention, access to the vasculature ismade via the vena femoralis (FIG. 15B) at a location remote from thepatient's abdomen (e.g., the thigh, groin, etc.) in order to allowendovascular advancement of one-way valve 300 to the selected internalanatomical site.

Steerable access sheath 475 is then advanced into the blood vessel(e.g., the jugular vein) and advanced endovascularly until flexibledistal end 480 of steerable access sheath 475 is proximate to theimplantation site. The surgeon then selectively articulates flexibledistal end 480 of steerable access sheath 475 (e.g., via handle 470)until flexible distal end 480 of steerable access sheath 475appropriately addresses the side wall of the blood vessel forfacilitating implantation of one-way valve 300.

Guidewire 410 is then inserted into passageway 495 of handle 470 andthrough flexible access sheath 475 and advanced endovascularly until theguidewire is disposed at the internal anatomical site (e.g., the desiredlocation within the inferior vena cava). See FIG. 37 . It should beappreciated that, if desired, guidewire 410 may be advanced to theinternal anatomical site first, and flexible access sheath 475 can beadvanced over the guidewire.

Dilator 415 is then passed over guidewire 410 and advanced to theinternal anatomical site (FIG. 37 ). Tapered distal end 435 of dilator415 is then passed through the side wall of the blood vessel (andthrough interstitial tissue, the peritoneal layer, etc.) in order toform an enlarged passageway sized to received one-way valve 300 (FIG. 38).

Deployment catheter 420, carrying one-way valve 300 within lumen 455 ofthe deployment catheter, is then advanced to the internal anatomicalsite by passing deployment catheter 420 over guidewire 410 and overdilator 415. After distal end 445 of deployment catheter 420 is passedthrough the side wall of the blood vessel, through the interstitialtissue and through the peritoneal layer, such that distal end 445 isdisposed within the abdominal cavity (FIG. 38 ), dilator 415 andguidewire 410 are removed (i.e., withdrawn proximally) leavingdeployment catheter 420 in place within the anatomy (FIG. 39 ).

It should be appreciated that at this time, one-way valve 300 isdisposed just inside the distal end of deployment catheter 420 (or,alternatively, one-way valve 300 may be advanced to a position justinside the distal end of deployment catheter 420). When one-way valve300 is disposed in the desired position, the surgeon deploys one-wayvalve 300 by moving pushrod 465 distally against the power of spring 460such that pushrod 465 engages one-way valve 300 and ejects the proximalend of one-way valve 300 out of deployment catheter 420, such that legs375 expand radially outward, with distally-directed contact surfaces 380contacting the outer wall of the blood vessel (or the interstitialtissue covering the outer wall of the blood vessel).

Next, deployment catheter 420 is withdrawn further until distalconnection element 320, which is disposed within the interior of theblood vessel (e.g., the interior of the inferior vena cava), isuncovered. As this occurs, radially-constricted legs 385 expand radiallyoutward into their radially-expanded configuration, withproximally-directed contact surfaces 390 contacting the inner wall ofthe blood vessel. If necessary, steerable access sheath 475 can also beretracted slightly in order to provide room for radial expansion of legs385. At this point, one-way valve 300 is locked in position within theside wall of the blood vessel. See FIGS. 40 and 41 .

Finally, deployment catheter 420 is withdrawn so as to remove thedeployment catheter from the patient's body and steerable access sheath475 is also withdrawn, leaving one-way valve 300 implanted within theside wall of the blood vessel.

At the conclusion of the procedure, one-way valve 300 is securelyanchored within the side wall of the blood vessel (e.g., the inferiorvena cava), held in position by proximal connection element 315 anddistal connection element 320. Inlet 345 of tube 325 of one-way valve300 is fluidically connected to the abdominal cavity and valve elementoutlet 367 of tubing 355 of valve element 310 of one-way valve 300 isfluidically connected to the blood vessel (e.g., the interior of theinferior vena cava). As a result, fluid (e.g., fluid resulting fromascites) is able to flow from the abdominal cavity, into inlet 345 oftube 325, along lumen 340 of tube 325, through tubing 355 of valveelement 310 and out valve element outlet 367 of tubing 355 into theinterior of the blood vessel (e.g., the interior of the inferior venacava), but fluid is unable to flow in the opposite direction. Thus,fluid can exit the abdominal cavity and enter the blood vessel withoutthe need for a long catheter or the need for external access to theabdominal cavity.

Novel Valve for Draining Body Fluid from a Body Cavity, and inParticular for Draining Fluid from the Pleural Cavity

In addition to the foregoing, it should also be appreciated that any ofthe one-way valves discussed above (e.g., one-way valve 25, one-wayvalve 25A, etc.) and/or any of the delivery systems discussed above(e.g., delivery system 110) may also be used to drain fluid from a firstbody cavity into a second body cavity, and/or to drain fluid from a bodycavity into the venous system of the patient.

By way of example but not limitation, one such instance where it may bedesirable to drain fluid from a first body cavity into a second bodycavity is where there is fluid build-up in the pleural cavity (i.e., thespace between the visceral pleural layer and the parietal plural layer)such as can occur in association with conditions such as cancer, heartdisease, etc. Such fluid-build up in the pleural cavity is commonlyreferred to as pleural effusion.

In accordance with the present invention, pleural effusion may betreated by implanting a novel one-way valve in the body such that theproximal end of the one-way valve is in fluid communication with thefluid inside the pleural cavity and the distal end of the one-way valveis in fluid communication with the abdominal cavity.

To this end, and looking now at FIGS. 43-45 , there is shown a novelone-way valve 500 formed in accordance with the present invention whichis sized and configured for implantation into a patient's body so as tofacilitate draining of a first body cavity (e.g., the pleural bodycavity) to a second body cavity (e.g., the abdominal cavity), and/or tofacilitate draining of a first body cavity (e.g., the pleural cavity) tothe venous system of the patient (e.g., the vena cava). One-way valve500 preferably comprises a proximal end 505, a distal end 510 and a body515 extending therebetween. If desired, body 515 of one-way valve 500may be structured and/or textured so as to facilitate implantation ofone-way valve 500 into the body of a patient. By way of example but notlimitation, body 515 may comprise a “stent structure” (FIG. 43 ) forpromoting ingrowth of adjoining tissue and/or for anchoring body 515 inthe tissue of the patient.

Body 515 comprises a tube 520 having an inlet 525 disposed at proximalend 505 of one-way valve and an outlet 530 disposed at distal end 510 ofone-way valve 500, with a lumen 535 extending therebetween. In onepreferred form of the invention, tube 520 comprises expandedpolytetrafluoroethylene (ePTFE). The length of body 515 of one-way valve500 can be selected such that the length of tube 520 of one-way valve500 is at least equal to the thickness of the tissue (e.g., thediaphragm) into which one-way valve 500 is to be implanted, plus thethickness of tissue which tube 520 will need to extend through in orderto reach the pleural cavity (e.g., the parietal pleura, etc.).

A valve element 540 (FIG. 45 ) is preferably disposed in lumen 535 oftube 520 intermediate inlet 525 and outlet 530, with valve element 540being configured to permit one-way flow of fluid through lumen 535 frominlet 525 to outlet 530, but to prevent fluid from flowing in theopposite direction (i.e., from outlet 530 to inlet 525).

In one preferred form of the invention, valve element 540 comprises aone-way, slit-type valve such that fluid may enter into inlet 525, passthrough the proximal portion of lumen 535, pass through valve element540, pass through the distal portion of lumen 535 and exit out of outlet530, but which does not allow fluid to flow in the opposite direction(i.e., from the abdominal cavity, through valve element 540 and into thepleural cavity). As a result, when one-way valve 500 is implanted intothe body of a patient such that inlet 525 is open to fluid disposed in afirst body cavity (e.g., the pleural cavity) and outlet 530 is open tothe interior of a second body cavity (e.g., the abdominal cavity), fluidcan flow from the first body cavity (e.g., the pleural cavity), throughone-way valve 500 and into the second body cavity (e.g., the abdominalcavity), but fluid cannot flow in the opposite direction.

It should be appreciated that valve element 540 is preferably configuredsuch that valve element 540 is “closed” (i.e., does not permit fluid toflow) until the pressure differential between (i) the pressure of thefluid entering inlet 525, and (ii) the pressure of the fluid enteringoutlet 530, rises above a pre-determined threshold. By way of examplebut not limitation, valve element 540 may be configured to “open” (i.e.,allow fluid to flow from inlet 525, through valve element 540 and out ofoutlet 530) when the pressure differential on the two sides of the valveelement is less than 10 mmHg and, more preferably, when the pressuredifferential is between 2 mmHg and 5 mmHg.

Alternatively and/or additionally, if desired, outlet 530 of tube 520may comprise valve element 540. By way of example but not limitation,distal end 530 of tube 520 may be flattened, e.g., in the manner of a“duckbill valve” so as to form valve element 540, whereby to permitfluid to flow from inlet 525 through lumen 535, through valve element540 (i.e., the flattened proximal portion of tube 520), and out outlet530 while preventing fluid from flowing in the opposite direction (i.e.,from outlet 530 through lumen 535 and out inlet 525).

Novel Method for Draining Body Fluid from a First Body Cavity to aSecond Body Cavity, and in Particular for Draining Fluid from thePleural Cavity to the Abdominal Cavity

If desired, a one-way valve may be implanted into the body such that theone end of the one-way valve is in fluid connection with a first bodycavity, and the other end of the one-way valve is in fluid communicationwith a second body cavity. For purposes of illustration, the presentinvention will now be discussed in the context of a one-way valveimplanted between the pleural cavity and the abdominal cavity, however,it should be appreciated that a one-way valve may be implanted so as tospan (and be in fluid connection with) substantially any two bodycavities without departing from the scope of the present invention.

As will also hereinafter be discussed in further detail, one-way valve500 may be implanted using an “abdominal approach” in which the one-wayvalve is advanced from the abdominal cavity, through the diaphragm, andinto the pleural cavity. Alternatively, one-way valve 500 may beimplanted using an “thoracic approach” in which the one-way valve isadvanced from the pleural cavity, through the diaphragm, and into theabdominal cavity.

Looking now at FIGS. 46-48 , in one preferred form of the invention,novel one-way valve 500 may be implanted into the body such that inlet525 of tube 520 located at proximal end 505 of one-way valve 500 isdisposed in, and fluidically connected to, a pleural cavity 545 and suchthat outlet 530 of tube 520 located at distal end 510 of one-way valve500 is disposed in, and fluidically connected to, the abdominal cavity550, such that body 515 of one-way valve 500 passes through theintervening tissue (i.e., the diaphragm, the parietal pleura, etc.)disposed between pleural cavity 545 and abdominal cavity 550.

More particularly, and still looking at FIGS. 46-48 , in one preferredform of the invention, one-way valve 500 is implanted endoscopically(e.g., laparoscopically or thorascoscopically) by accessing theabdominal cavity (e.g., via a surgical access cannula), locating anappropriate position on the diaphragm for implantation of one-way valve500 (e.g., taking into consideration any diseased tissue proximate tothe diaphragm, connective tissue, muscular tissue, etc.) and thenpuncturing (e.g., with a needle, puncturing device, etc.) diaphragm 555and the parietal pleura 560 (and any intervening tissue) so as to forman “access tunnel” through the tissue disposed between abdominal cavity550 and pleural cavity 545. If desired, a guidewire (not shown) may beinserted into the “access tunnel” so as to guide insertion of one-wayvalve 500 into the “access tunnel.” Alternatively and/or additionally, adelivery system (e.g., the aforementioned delivery system 110) may beused to deliver one-way valve 500 to the surgical site in the mannerdiscussed above.

After the “access tunnel” has been formed, proximal end 505 of one-wayvalve 500 is advanced into “access tunnel” (e.g., over a guidewire, ifused), through the diaphragm 555, through the parietal pleura 560 andinto the pleural cavity 545 such that inlet 525 of tube 520 of one-wayvalve 500 is fluidically connected to the pleural cavity, and such thatoutlet 530 of tube 520 of one-way valve 500 is disposed in, andfluidically connected to, abdominal cavity 550. Body 515 preferablyengages diaphragm 555 and/or any intervening tissue that body 515 ofone-way valve 500 passes through.

Once one-way valve 500 is implanted such that it fluidically connectspleural cavity 545 with abdominal cavity 550, fluid disposed in pleuralcavity 545 is able to flow enter one-way valve 500 via inlet 525 of tube520, flow through lumen 535 of tube 520, pass through one-way valve 540,and exit out of outlet 530 of tube 520 into abdominal cavity 550.

If desired, a camera (e.g., a surgical camera inserted via an accessportal into the abdominal cavity) may be used by the surgeon in order toensure correct device placement and/or to inspect for blood dryness,etc. After the device is implanted in the desired position (andconfirmed by the surgeon), the delivery device (if used), guidewire,camera(s), surgical access cannula(s), etc. are removed from thesurgical site and any access portals are closed and dressed.

As a result, fluid can now be continuously drained from pleural cavity545 to abdominal cavity 550, where the fluid may be reabsorbed by thebody (or drained from the abdominal cavity via another method), wherebyto treat pleural effusion.

It should be appreciated that one-way valve 500 may be implanted intothe diaphragm so as to fluidically connect pleural cavity 545 toabdominal cavity 550 at substantially any location where the surroundinganatomy permits implantation. By way of example but not limitation,one-way valve 500 may be implanted into the medial, paraaortal portionof the diaphragm (i.e., near where the central tendon is located) asshown in FIG. 46 . By way of further example but not limitation, one-wayvalve 500 may be implanted into the left portion of the diaphragm asshown in FIG. 47 . By way of further example but not limitation, one-wayvalve 500 may be implanted into the central area of the left portion ofthe diaphragm as shown in FIG. 48 . By way of still further example butnot limitation, one-way valve 500 may be implanted into the costalmuscle fibers of the diaphragm (i.e., the outer portion of thediaphragm). It should also be appreciated that, if desired, multipleone-way valves 500 may be implanted into the diaphragm so as tofluidically connect pleural cavity 545 to abdominal cavity 550.

Although implantation of one-way valve 500 has been discussed above inthe in the context of a laparoscopic approach (i.e., implanting one-wayvalve 500 into the diaphragm using an endoscopic, abdominal-to-pleuralcavity implantation approach), if desired, one-way valve 500 may beinstead implanted thoracosopically (i.e., one-way valve 500 may beimplanted by accessing the thoracic cavity/pleural cavity first, andthen inserting the distal end through the intervening tissue and thediaphragm so that the distal end of one-way valve 500 is disposed in theabdominal cavity).

Novel Method for Draining Body Fluid from a Body Cavity to a BloodVessel, and in Particular for Draining Fluid from the Pleural Cavity toa Veneous Blood Vessel

If desired, a one-way valve may be implanted into the body such that theone-way valve is in fluid connection with a first body cavity and with ablood vessel (e.g., the vena subclavia, the vena cava, etc.). Forpurposes of illustration, the present invention will now be discussed inthe context of a one-way valve implanted between the pleural cavity andthe vena cava so as to fluidically connect the pleural cavity and thevena cava, however, it should be appreciated that a one-way valve may beimplanted so as to fluidically connect substantially any body cavity andsubstantially any blood vessel without departing from the scope of thepresent invention.

Looking now at FIG. 49 , in one preferred form of the invention, novelone-way valve 500 is implanted into the body such that inlet 525 of tube520 located at proximal end 505 of one-way valve 500 is disposed in, andfluidically connected to, a pleural cavity 545 such that outlet 530 oftube 520 located at the distal end 510 of one-way valve 500 is disposedin, and fluidically connected to, the interior of a venous blood vessel(e.g., the vena cava) 565 such that one-way valve 500 passes through theintervening disposed between the pleural cavity 545 and venous bloodvessel 565, whereby to fluidically connect pleural cavity 545 to venousblood vessel 565.

More particularly, and still looking at FIG. 49 , in one preferred formof the invention, one-way valve 500 is implanted using an endovascularapproach. After the surgeon has located a suitable blood vessel forimplantation and identified a suitable implantation site (i.e., asuitable blood vessel for receiving one-way valve 500 proximate to thepleural cavity), a puncture device (e.g., the aforementioned puncturedevice 115) is used to puncture the skin of the patient so as to accessthe interior of the blood vessel. In a preferred form of the invention,access to the vasculature is made by puncturing the jugular vein using apuncture device and then the one-way valve is advanced to the selectedinternal site endoluminally. Alternatively, access to the vasculaturemay be achieved by puncturing the subclavian vein (also known as thevena subclavia) and then one-way valve is advanced to the internal siteendoluminally. In still another form of the invention, access to thevasculature is made via the vena femoralis at a location remote from thepatient's chest (e.g., the thigh, groin, etc.) in order to allowendoluminal advancement of one-way valve 500 to the selected internalanatomical site.

When one-way valve 500 (and/or the appropriate delivery system) isdisposed at the desired location along venous blood vessel 565 (e.g., inthe vena cava proximate to the pleural cavity), an “access tunnel” isformed in the side wall of the vasculature so as to pass through theintervening tissue and into pleural cavity 545. The proximal end 505 ofone-way valve 500 is then advanced through the “access tunnel” and intopleural cavity 545 such that inlet 525 of tube 520 disposed at proximalend 505 of body 515 of one-way valve 500) is fluidically connected topleural cavity 545, and such that outlet 530 of tube 520 (disposed atdistal end 510 of body 515 of one-way valve 500) is fluidicallyconnected to the interior of venous blood vessel 565. If desired, aguidewire (not shown) may be inserted into the “access tunnel” so as toguide insertion of one-way valve 500 into the “access tunnel”.Alternatively and/or additionally, if desired, a delivery system (e.g.,the aforementioned delivery system 110) is to be used to deliver theone-way valve to the surgical site.

Body 515 preferably engages the side wall of the vasculature and/or theintervening tissue into which one-way valve 500 is implanted. Afterone-way valve 500 is implanted such that it fluidically connects pleuralcavity 545 with the interior of venous blood vessel 565, fluid disposedin pleural cavity 545 is able to enter one-way valve 500 via inlet 525of tube 520, flow through lumen 535 of tube 520, pass through one-wayvalve 540, and exit out of outlet 530 of tube 520 into venous bloodvessel 565.

If desired, an endoluminal ultrasound device (e.g., an ultrasound deviceinserted endoluminally and advanced to the surgical site) may be used bythe surgeon in order to ensure correct device placement and/or toinspect for blood dryness, etc. After the device is implanted in thedesired position (and confirmed by the surgeon), the delivery device (ifused), guidewire, ultrasound device, surgical access portal(s), etc. areremoved from the surgical site and any access portals are closed anddressed. As a result, fluid can now be continuously drained from pleuralcavity 545 to venous blood vessel 565, where the fluid is reabsorbed bythe body, whereby to treat pleural effusion.

It should be appreciated that multiple one-way valves 500 may beimplanted into the side wall of venous blood vessel 565 so as tofluidically connect pleural cavity 545 to the interior of venous bloodvessel 565 as discussed above. Alternatively and/or additionally,multiple one-way valves 500 may be implanted into the side wall ofmultiple venous blood vessels so as to fluidically connect pleuralcavity 545 to the interior of venous blood vessels as discussed above.

Although implantation of one-way valve 500 has been discussed above inthe in the context of a endoluminal approach (i.e., implanting one-wayvalve 500 into the side wall of a venous blood vessel using anendoluminal, venous blood vessel-to-pleural cavity implantationapproach), if desired, one-way valve 500 may be instead implantedthoracosopically (i.e., one-way valve 500 may be implanted by accessingthe thoracic cavity/pleural cavity first, and inserting the distal endof one-way valve 500 through the intervening tissue and the side wall ofveneous blood vessel 565 so that the distal end of one-way valve 500 isdisposed in the interior of the venous blood vessel).

Modifications of the Preferred Embodiments

It should be understood that many additional changes in the details,materials, steps and arrangements of parts, which have been hereindescribed and illustrated in order to explain the nature of the presentinvention, may be made by those skilled in the art while still remainingwithin the principles and scope of the invention.

What is claimed is:
 1. A method for treating pleural effusion in apatient, the method comprising: providing a valve comprising: a bodyhaving a distal end, a proximal end and a lumen extending therebetween;an inlet disposed at the proximal end of the body, the inlet beingfluidically connected to the lumen; an outlet disposed at the distal endof the body, the outlet being fluidically connected to the lumen; and atleast one valve element disposed in the lumen of the body, the at leastone valve element being a one-way valve element configured to permit thepassage of fluid in a single direction through the lumen of the body;and implanting the valve in the body of the patient such that the inletof the valve is fluidically connected to the pleural cavity of thepatient, and such that the outlet of the valve is fluidically connectedto a second body cavity; wherein the second body cavity comprises theabdominal cavity; wherein the valve is implanted in the body of thepatient by accessing the thoracic cavity and advancing the distal end ofthe body of the valve through the parietal pleura, through the diaphragmand into the abdominal cavity, such that once implanted in the patient,the proximal end of the body of the valve is disposed in the pleuralcavity, the distal end of the body of the valve is disposed in theabdominal cavity and the body of the valve passes through the parietalpleura and the diaphragm of the patient.
 2. A method according to claim1 wherein the body of the valve comprises a stent body, and furtherwherein the stent body is configured to promote ingrowth of adjacenttissue into the stent body so as to anchor the stent body in positionafter the valve is implanted in the body of the patient.
 3. A methodaccording to claim 1 wherein the at least one valve element is formedout of the distal end of the lumen by flattening the distal end of thelumen of the valve so as to form the valve element.
 4. A methodaccording to claim 1 wherein the length of the body of the valve is atleast equal to the thickness of the diaphragm plus the thickness of theparietal pleura plus the thickness of the interstitial tissue throughwhich the valve is to extend.
 5. A method according to claim 1 whereinthe at least one valve element is configured to allow the passage offluid therethrough when the pressure differential across the valveelement is less than 10 mmHg in a selected direction.
 6. A methodaccording to claim 1 wherein the at least one valve element isconfigured to allow the passage of fluid therethrough when the pressuredifferential across the valve element is less than 5 mmHg.
 7. A methodaccording to claim 1 the valve element is configured to allow thepassage of fluid therethrough when the pressure differential across thevalve element is less than 2 mmHg.
 8. A method according to claim 1wherein the body of the valve comprises a circular cross-section.
 9. Amethod according to claim 1 wherein the body of the valve is radiallycompressible.
 10. A method according to claim 1 wherein the body of thevalve comprises an expandable stent.
 11. A method according to claim 10wherein the expandable stent is a covered stent.